Combined Treatment with High-Dose Methotrexate, Vincristine and Procarbazine, without Intrathecal Chemotherapy, Followed by Consolidation Radiotherapy for Primary Central Nervous System Lymphoma in Immunocompetent Patients

Publisher： Karger

E-ISSN： 1423-0232|60|2|134-140

ISSN： 0030-2414

Source： Oncology, Vol.60, Iss.2, 2001-02, pp. : 134-140

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Rituximab with high‐dose methotrexate in primary central nervous system lymphoma

By  

AMERICAN JOURNAL OF HEMATOLOGY, Vol. 90, Iss. 12, 2015-12 ,pp. : 1149-1154

John Wiley & Sons Inc

Access to resources Recommend Favorite

Prognosis Factors in Japanese Elderly Patients with Primary Central Nervous System Lymphoma Treated with a Nonradiation, Intermediate-Dose Methotrexate-Containing Regimen

By  

Oncology Research and Treatment, Vol. 37, Iss. 7-8, 2014-05 ,pp. : 378-383

Karger

Access to resources Recommend Favorite

Hepatitis B Virus Reactivation in a Primary Central Nervous System Lymphoma Patient following Intrathecal Rituximab Treatment

By  

Acta Haematologica, Vol. 125, Iss. 3, 2010-12 ,pp. : 121-124

Karger

Access to resources Recommend Favorite

Chemotherapy for Osteosarcoma without High-Dose Methotrexate: Another Piece in the Puzzle

By  

Oncology Research and Treatment, Vol. 30, Iss. 5, 2007-04 ,pp. : 226-227

Karger

Access to resources Recommend Favorite

Pilot Trial of Systemic Methotrexate plus R-CHOP Regimen with Intrathecal Methotrexate for Simultaneous Central Nervous System and Systemic Diffuse Large B Cell Lymphoma

By  

Acta Haematologica, Vol. 133, Iss. 2, 2014-10 ,pp. : 179-182

Karger

Access to resources Recommend Favorite